Grant ID

98-RC-305-2

Illness

Bipolar Disorder

Primary Drug/Intervention

Ethosuximide

Primary Dosage

N/A

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Walden

Sample Size

15

Duration of Study Period for Each Subject

6 weeks

Outcome Measurements

YMRS

Results

There was no perceived benefit of ethosuximide given adjunctively to haloperidol in acute mania.

Publication

Walden J et al. Levetiracetam and ethosuximide in the treatment of acute mania in an open study with an on-off-on design. Bipolar Disorder 4 (supplement 1) 2002;114.

Link

N/A

PI Name

Joerg Walden

Degree

MD

Center

N/A

Institution

N/A

Address

City or Town

Frieburg

State or Province

N/A

Zip or Postal Code

N/A

Country

Germany

Email Address

JOERG_WALDEN@psyallg.ukl.uni-freiburg.de